Latest in: Press

Tagworks lands $65M for its take on Nobel-winning click chemistry in bid to expand ADC, radiopharma potential

A Dutch-American biotech is out with $65 million in Series A funding to get into the clinic with what it calls an expanded scope of the popular antibody-drug conjugates class after a decade of legwork iterating on the original click chemistry findings that led to last year’s Nobel Prize.
June 22, 2023

Tagworks’ click-to-release ADC approach draws $65M in series A round

By BioWorld Twelve years on from spinning out of Philips Healthcare, Tagworks Pharmaceuticals BV has raised $65 million in a series A round to take a new generation of antibody-drug conjugates (ADCs) based on click chemistry into the clinic. Read more.
June 22, 2023

Tagworks: using click chemistry to make ADCs more applicable and radiotherapies safer

By BioCentury Netherlands-based Tagworks is using click chemistry to simultaneously accomplish on-target activation of ADCs and off-target deactivation of radiopharmaceuticals. After spinning out of Philips Healthcare in 2011, the company has announced a $65 million series A round co-led by Ysios Capital and Gilde Healthcare. Download the complete article here.
June 22, 2023

Click wins the Nobel !

Tagworks congratulates Carolyn Bertozzi, Morten Meldal and Barry Sharpless with winning the Nobel Prize in Chemistry 2022 for the development of click chemistry and bioorthogonal chemistry ! Their discoveries made a massive impact on many areas of science and form the foundation of Tagworks' Click-to-Release approach.  
October 5, 2022

Click and bioorthogonal chemistry win 2022 Nobel Prize in Chemistry

Carolyn R. Bertozzi, Morten Meldal, and K. Barry Sharpless receive prize for their work on reactions that quickly link molecules and the application of the reactions in living cells Three scientists have won the 2022 Nobel Prize in Chemistry: Carolyn R. Bertozzi of Stanford University, Morten Meldal of the University …
October 5, 2022

Click chemistry targets antibody-drug conjugates for the clinic

Bioorthogonal chemistry, already a workhorse of drug discovery research, prepares for the leap into human testing. Researchers at the Memorial Sloan Kettering Cancer Center in New York are preparing the first test in humans of a new type of diagnostic that combines a radioisotope and antibody via bioorthogonal ‘click’ chemistry. …
August 21, 2019

Tagworks featured in BioCentury

Tagworks is featured in a BioCentury article on the state of the art and clinical prospects of in vivo click chemistry.
June 27, 2017

Curious about what we do? Get in touch!


About    Our Technology   Pipeline    Join us    News    Contact

T +31 85 800 8550

Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra